Evidence map›Paper›PMID 41034474›Full record

ReviewNature protocols2026

NanoVar: a comprehensive workflow for structural variant detection to uncover the genome's hidden patterns.

Asmaa Samy, Cheng Yong Tham, Matthew Dyer, Touati Benoukraf

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Asmaa SamyDivision of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Cheng Yong ThamCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Matthew DyerDivision of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Touati BenoukrafDivision of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. tbenoukraf@mun.ca.ORCID 0000-0002-4789-8028

Funding

Canada Research Chairs (Chaires de recherche du Canada) CRC-2022-00285
6 · The paper itself

Abstract

Structural variants (SVs) contribute significantly to genomic diversity and disease predisposition as well as development in diverse species. However, their accurate characterization has remained a challenge because of their complexity and size. With the rise of third-generation sequencing technology, analytical strategies to map SVs have been revisited, and software such as NanoVar, a free and open-source package designed for efficient and reliable SV detection in long-read sequencing data, has facilitated their studies. NanoVar has been shown to work effectively in various published genomic studies, including research on genetic disorders, population genomics and genome analysis of non-model organisms. In this article, we describe in detail all the steps of the NanoVar protocol and its interplay with other platforms for SV calling in whole-genome long-read sequencing data such that researchers with minimal experience with command-line interfaces can easily carry out the protocol. It also provides exhaustive instructions for diverse study designs, including single-sample analyses, cohort studies and genome instability analyses. Finally, the protocol covers SV visualization, filtering and annotation details. Overall, users can identify and analyze SVs in a typical human dataset with a conventional computational setup in ~2-5 h after read mapping.

Indexed as

Genome, HumanGenomicsGenomic Structural VariationSoftwareHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNAWorkflow

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.